)
)
Using Proteomics for Drug Discovery and Target ID for Major Depressive Disorders
-
Explore how proteomics technologies are applied to identify and validate novel drug targets for major depressive disorder (MDD).
-
Discuss strategies for integrating proteomic data into drug discovery pipelines to accelerate therapeutic development.
-
Highlight recent case studies and breakthroughs in using proteomics to uncover biological pathways implicated in MDD
